Synergistic effect of bromocriptine and tumor necrosis factor-α on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm

Figure 1 RT-PCR of TNFmRNA. M: Marker; lanes 1 and 2: TNF group, BCT group; lanes 3 and 4: HepG₂ group, ADM group.

Figure 2 Size of tumor after chemotherapy in groups of HepG₂ (A) and BCT (B).

Figure 3 Growth curve of tumor in each group after chemotherapy.

Figure 4 Histological characteristics of tumor in HepG₂ group (A) and BCT group (B).

Figure 5 Pgp protein expression in groups of HepG₂ (A), ADM (B), BCT (C), and TNF (D).

Figure 6 Expression of MDR1mRNA (A, 176 bp) and LRPmRNA (B, 237 bp).

Figure 7 HHC cell apoptosis in groups of BCT (A), TNF (B), ADM (C), and HepG₂ (D).